More than 200,000 people worldwide are estimated to be living with Amyotrophic lateral sclerosis (ALS). That number is expected to rise in the coming decades as people live longer. For many people with ALS, and the families who care for them, one question comes up again and again: how do I find a clinical trial that may be right for me?
Clinical trials are central to ALS research. They help scientists test new approaches and learn more about the disease. For people living with ALS, taking part can also be a way to play an active role in their care. Even so, finding the right trial can feel overwhelming. There are several databases to search, detailed eligibility criteria, and important choices to weigh along the way.
The good news is that trusted tools can help you explore ALS clinical trials. And personalized support can help you focus on the options that fit your situation best.
While ALS research has made real progress in recent years, there is still an urgent need for new treatments. Clinical trials play a key role here. They test possible therapies, build scientific understanding, and help improve care for people diagnosed with ALS in the future.
For people with ALS and their families, exploring clinical trials can be a way to take an active role in their own care. A trial may or may not turn out to be the right fit. Either way, knowing what research is out there can help you make more informed decisions.
Many people search for the “most promising” ALS clinical trials, hoping to find the ones most likely to help. But it helps to understand something first: no one, not even researchers, can predict how an ongoing trial will turn out. No trial can be called more likely to succeed than another. That uncertainty is exactly why clinical trials are run.
A more useful question is this: which ALS clinical trials may be most relevant to you? The answer depends on your diagnosis, disease features, genetic profile, and practical circumstances. It does not depend on claims about results. To focus on the studies worth exploring, review eligibility carefully and seek guidance where it helps.
Several organizations share information about active and recruiting ALS clinical trials. Each one works a little differently, so it helps to know what each is best for.
Resource |
What it includes |
What it mainly does |
How it helps |
Key differences |
| ClinicalTrials.gov | U.S. and global clinical trial listings
|
Provides a large public database of clinical trials | Lets you search for ALS trials by condition, location, status, and study type | Broadest public registry, but often technical and hard to interpret |
| NEALS Trials Search (Network of ALS Excellence) | ALS-focused trials, mainly across the NEALS research network
|
Offers an ALS-specific trial search experience | Makes it easier to find ALS trials in the U.S. | More disease-specific than ClinicalTrials.gov, but still primarily a search tool |
| Trial Navigator by ALS Therapy Development Institute (TDI) | ALS clinical trial listings with patient-friendly filters
|
Helps you explore trials based on preferences and circumstances | Supports easier browsing by location, trial type, and practical considerations | More guided than a raw registry, but still focused on trial discovery |
| ALS Signal by I AM ALS | Global disease-modifying ALS interventional trials (data from ClinicalTrials.gov), plus US/Canada expanded access programs
|
Helps you understand what is being studied in ALS | Makes ALS research easier to understand for people and caregivers | Patient-built dashboards and strong educational and community focus |
| myTomorrows | Integrated trial data from ClinicalTrials.gov, the EU Clinical Trials Register / EudraCT, and ISRCTN, combined with AI-assisted pre-screening and human navigation
|
Helps identify, evaluate, and prioritize potentially relevant clinical trial options based on individual patient characteristics. | Supports the move from “what trials exist?” to “which options may be relevant to me, and what should I do next?” | Combines multiple registries with personalized guidance, helping you identify and prioritize potentially relevant trials rather than simply producing a list of studies |
While trial databases can help people discover trials, determining which ALS clinical trials may be relevant often requires evaluating eligibility criteria, timing considerations, genetic characteristics, geographic access, and recruiting status.
Finding ALS clinical trials feels more manageable when you break it into steps:

No. You do not need a doctor’s referral to search for ALS clinical trials, and anyone can look into the trials that are available. Still, your healthcare team plays an important role. They can help you choose a trial, and they guide you through screening and enrollment. It therefore is a good idea to discuss any trials you are considering with your neurologist and care team.
A good approach brings a few things together. It uses trusted trial databases, personalized guidance, and conversations with your healthcare provider.
Resources such as ClinicalTrials.gov, NEALS, ALS TDI, I AM ALS, and myTomorrows can help you find and explore ALS studies. These resources provide information about active clinical trials and ongoing ALS research. Most let you search for trials yourself. myTomorrows works a little differently. It pulls together trial data from several registries. Then it uses AI to match your personal profile to relevant trials, with support from a patient navigator. Your navigator will support you to identify any clinical trial options that may be relevant to you.
Finding a clinical trial is often just the beginning. You may still need to understand the eligibility criteria. You also need to weigh practical points, such as travel and time. And you need to check whether a trial fits your medical history, disease stage, treatment goals, and personal preferences.
For many people living with ALS, the challenge is not finding clinical trials. It is understanding what options might be relevant for them and how to access them. Healthcare providers can offer important clinical guidance. Services such as myTomorrows’ patient navigation can help too. They can help you find trials that may be relevant, understand eligibility criteria, and work out the next steps.
For many people, it is easier to spot possible trials than to know if they actually qualify. Several things can affect whether you are eligible, including:
A trial may sound relevant from its title alone. But the eligibility criteria are often far more specific than they first appear. Checking these details on your own can take a lot of time. That is one reason many people and caregivers find guidance helpful when narrowing down the options.
For many people with ALS, getting into a trial depends on more than whether you medically qualify. It can also depend on how long it took to get diagnosed and when you were referred. Where you live and whether a trial is still open matter too. Some trials also accept people only within a set time after symptoms begin1.
Eligibility differs from one trial to the next, so no single answer fits every trial. Many factors can affect whether you qualify. These include your disease stage, time since diagnosis, breathing function, genetic profile, current medicines, and past treatments. The best way to understand your eligibility is to review a trial’s inclusion and exclusion criteria. Your care team or a patient navigator can help you do this.
You don’t have to work it out alone. A myTomorrows patient navigator can review your diagnosis, treatment history, recent neurologist notes, respiratory function results, and any genetic or biomarker testing to help identify ALS clinical trials that may be relevant, and explain what taking part would actually involve. They can also help explain eligibility criteria, clarify what participation may involve, and answer questions about the next steps.
For some genetic forms of ALS, timing can matter a great deal. Researchers are studying whether treatment should begin before symptoms appear, rather than after the disease has already progressed.
For example, some trials in SOD1-associated ALS have included people who carry a known disease-causing SOD1 variant but do not yet have symptoms. Research is also ongoing in other genetic forms of ALS, including those associated with C9ORF72 and FUS, where genetic testing may help identify people who could be eligible for certain research opportunities.
No clinical trial can guarantee eligibility or enrollment. But people with a known genetic form of ALS may have a clearer picture of their options. That is because researchers often look for specific genetic and biomarker profiles. This is one reason early awareness matters. Genetic counseling, genetic testing, and regular monitoring can all be important for families affected by inherited ALS.
ALS trial access has shown that diagnostic and referral delays can significantly reduce the number of clinical trial opportunities that remain available to people, even when suitable trials exist.
Finding a trial is the first step. Enrollment can only begin after you have been referred to the site and checked against the trial’s inclusion and exclusion criteria. In other words, the process starts with finding trials that fit your medical history, disease characteristics, and eligibility profile. But it does not end there.
Finding a relevant trial does not guarantee enrollment, but it is a necessary first step. The better you understand the trial landscape, the easier it is to focus on realistic options. It also helps you have informed conversations with your care team.

Reviewing several databases by hand can be confusing and take a lot of time. So, some people and caregivers choose to start with personalized clinical trial navigation support instead.
Clinical research can be hard to navigate. This is especially true while juggling medical appointments, caregiving, and daily life with ALS. A patient navigator may help by:
At myTomorrows, patient navigators work one-on-one with people and caregivers. They help you better understand clinical trial options and the pathways open to you. This support is not a substitute for medical advice. It is personalized information that helps you make informed decisions, alongside your healthcare team, with more confidence and clarity.
myTomorrows patient navigators have already supported over 750 patients people living with ALS in exploring their clinical trial options.
Once you have found a trial you are interested in, it helps to gather key information in advance. This makes referral to a trial site and conversations with research teams easier. Consider gathering:
Trials begin with a site screening process. It checks whether a participant meets the trial’s specific criteria. Screening is a routine part of clinical research, and being matched doesn’t guarantee enrollment. Not qualifying for one trial does not mean other options are closed to you.
Some ALS clinical trials offer remote or hybrid participation, while others require visits to a research site. Requirements vary by trial and may include virtual visits, local testing, home-based assessments, or travel to a trial center. Because travel and location can affect trial access for some people living with ALS, it is worth considering these practical considerations early when exploring potential options.
Not qualifying for one trial does not rule out future ones. Different trials have different eligibility criteria, and new ALS research keeps emerging. So, someone who is not eligible for one trial may still qualify for others. A patient navigator can help you keep track of options as new trials open.
Not qualifying for one trial does not rule out other opportunities, including, in some cases, expanded access to investigational treatments.
People and caregivers often run into a few common challenges when exploring ALS trials:
Finding an ALS clinical trial can feel daunting, but you don’t have to do it alone. Resources such as ClinicalTrials.gov, NEALS, ALS TDI, I AM ALS and myTomorrows offer valuable ways to explore available trials. And your healthcare team can help you make sense of what you find.
Finding trials is often the first step. Understanding eligibility criteria, timing considerations, and practical factors such as travel and site availability can be just as important. Personalized navigation support can turn all this information into clear next steps. It does this by focusing on the options most relevant to your situation.
If you’d like help understanding which ALS clinical trials may be most relevant to your situation, a myTomorrows patient navigator can talk it through with you — at no cost and with no obligation.
Expert Patient Navigator and Commerical Partnerships at myTomorrows
Madeleine Pagel is an Expert Patient Navigator in Commercial Partnerships at myTomorrows, where she drives clinical site engagement and strengthens the partnerships that connect patients to trial opportunities. A pharmacist by training, Madeleine brings clinical expertise together with a focus on the relationships and processes that make referrals work — onboarding new sites, keeping communication responsive, and supporting key initiatives such as conferences and webinars. That combination helps improve referral outcomes across the patient journey, from higher acceptance rates to faster closure times and stronger patient conversion.
Madeleine holds a PharmD with a minor in Health Education from the University of South Florida College of Pharmacy and is a pharmacist licensed in New York State, combining clinical pharmacy training with hands-on experience in site engagement and commercial partnerships. She previously worked as an associate scientist in the Troen Lab at the University at Buffalo, adding a research grounding to that clinical foundation.
Madeleine Pagel 14 Aug 2026